INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

74 hedge funds and large institutions have $190M invested in Inozyme Pharma in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 8 closing their positions.

Holders
74
Holders Change
+25
Holders Change %
+51.02%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
33
Increased
25
Reduced
12
Closed
8
Calls
$126K
Puts
$263K
Net Calls
-$137K
Net Calls Change
+$75K

Top Buyers

1
BlackRock
1
BlackRock
New York
$10.8M
2
Millennium Management
2
Millennium Management
New York
$12.3M
3
State Street
3
State Street
Massachusetts
$3.12M
4
PBPIA
4
Pivotal bioVenture Partners Investment Advisor
California
$20.4M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$3.44M

Top Sellers

1
DTC
1
Deep Track Capital
Connecticut
$9.16M
2
SFM
2
Sphera Funds Management
Israel
$6.31M
3
Citadel Advisors
3
Citadel Advisors
Florida
$811K
4
SB
4
Samsara BioCapital
California
$0
5
CA
5
CHI Advisors
New York
$6.66M
Name Market Value Shares Shares
Change 		Shares
Change %
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$23.7M 4,250,000 -15,138 -0.4%
PBPIA
2
Pivotal bioVenture Partners Investment Advisor
California
$20.4M 3,661,518 +447,932 +14%
SI
3
Sofinnova Investments
California
$20.4M 3,655,308 – –
RSCM
4
Rock Springs Capital Management
Maryland
$19.1M 3,428,084 +213,184 +7%
NMC
5
NEA Management Company
Maryland
$13.6M 2,437,689 – –
Millennium Management
6
Millennium Management
New York
$12.3M 2,206,158 +515,083 +30%
BlackRock
7
BlackRock
New York
$10.8M 1,939,660 +1,488,467 +330%
DTC
8
Deep Track Capital
Connecticut
$9.16M 1,644,021 -1,605,979 -49%
Vanguard Group
9
Vanguard Group
Pennsylvania
$7.78M 1,395,910 +67,620 +5%
CA
10
CHI Advisors
New York
$6.66M 1,195,027 -147,164 -11%
SFM
11
Sphera Funds Management
Israel
$6.31M 1,131,967 -649,891 -36%
AAA
12
Affinity Asset Advisors
New York
$4.19M 751,796 – –
Fidelity Investments
13
Fidelity Investments
Massachusetts
$4.17M 748,834 +45,838 +7%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.44M 617,459 +376,251 +156%
State Street
15
State Street
Massachusetts
$3.12M 560,842 +462,787 +472%
MB
16
MPM BioImpact
Massachusetts
$1.82M 326,921 +93,193 +40%
Northern Trust
17
Northern Trust
Illinois
$1.67M 300,383 +254,501 +555%
WP
18
Woodline Partners
California
$1.61M 288,827 +288,827 New
LCM
19
Laurion Capital Management
New York
$1.39M 250,368 -21,432 -8%
Walleye Capital
20
Walleye Capital
New York
$1.34M 241,071 +241,071 New
Renaissance Technologies
21
Renaissance Technologies
New York
$1.33M 239,200 +53,100 +29%
DMKJ
22
David M. Knott Jr
$1.23M 220,000 +60,000 +38%
OMC
23
Overbrook Management Corp
New York
$1.22M 219,326 – –
Two Sigma Advisers
24
Two Sigma Advisers
New York
$1.18M 211,000 +211,000 New
EI
25
EAM Investors
California
$982K 176,228 +176,228 New
1
2 3 4